Disseminated Scedosporium/Pseudallescheria infection after double-lung transplantation in patients with cystic fibrosis

Journal of Clinical Microbiology

Volumn 48, Issue 5, 2010, Pages 1978-1982

  Morio, Florent ^a,b   Horeau Langlard, Delphine ^c   Gay Andrieu, Françoise ^a,b   Talarmin, Jean Philippe ^c   Haloun, Alain ^c   Treilhaud, Michelle ^c   Despins, Philippe ^c   Jossic, Frédérique ^c   Nourry, Laurence ^c   Danner Boucher, Isabelle ^c   Pattier, Sabine ^c   Bouchara, Jean Philippe ^d   Le Pape, Patrice ^a,b   Miegeville, Michel ^a,b  

^a HÔTEL DIEU   (France)

^b UNIVERSITÉ DE NANTES   (France)

^c NANTES UNIVERSITY HOSPITAL   (France)

^d ANGERS UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CASPOFUNGIN; FOSCARNET; GANCICLOVIR; TERBINAFINE; VALGANCICLOVIR; VORICONAZOLE;

ADULT; ANAMNESIS; ARTICLE; BIOPSY; BRAIN INFECTION; BRAIN ISCHEMIA; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CYSTIC FIBROSIS; CYTOMEGALOVIRUS INFECTION; FATALITY; FEMALE; FUNGUS CULTURE; HISTOPATHOLOGY; HUMAN; LUNG TRANSPLANTATION; MYCOSIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PETRIELLIDIUM BOYDII; PRIORITY JOURNAL; PSEUDALLESCHERIASIS; SCEDOSPORIUM;

ADULT; ANTIFUNGAL AGENTS; BRAIN; CHEMOPREVENTION; CYSTIC FIBROSIS; DNA, FUNGAL; ECHINOCANDINS; FATAL OUTCOME; FEMALE; HUMANS; LUNG DISEASES, FUNGAL; LUNG TRANSPLANTATION; MAGNETIC RESONANCE IMAGING; MICROBIAL SENSITIVITY TESTS; MICROSCOPY; MOLECULAR SEQUENCE DATA; NAPHTHALENES; PSEUDALLESCHERIA; PYRIMIDINES; RNA, FUNGAL; RNA, RIBOSOMAL, 28S; SCEDOSPORIUM; SEQUENCE ANALYSIS, DNA; TRIAZOLES;

PSEUDALLESCHERIA BOYDII;

EID: 77951874925     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.01840-09     Document Type: Article

References (31)

1. Alastruey-Izquierdo, A., M. Cuenca-Estrella, A. Monzon, and J. L. Rodriguez-Tudela. 2007. Prevalence and susceptibility testing of new species of Pseudallescheria and Scedosporium in a collection of clinical mold isolates. Antimicrob. Agents Chemother. 51:748-751.
2. Albernaz, V., B. Huston, M. Castillo, S. Mukherji, and T. Bouldin. 1996. Pseudallescheria boydii infection of the brain: imaging with pathologic confirmation. Am. J. Neuroradiol. 17:589-592.
3. Berge, M., R. Guillemain, V. Boussaud, M. H. Pham, P. Chevalier, A. Batisse, C. Amrein, E. Dannaoui, M. A. Loriot, A. Lillo-Le Louet, and E. M. Billaud. 2009. Voriconazole pharmacokinetic variability in cystic fibrosis lung transplant patients. Transpl. Infect. Dis. 11:211-219.
4. Blyth, C. C., A. Harun, P. G. Middleton, S. Sleiman, O. Lee, T. C. Sorrell, W. Meyer, and S. C. Chen. 11 November 2009, posting date. Detection of occult Scedosporium species in respiratory tract specimens from patients with cystic fibrosis (CF) by use of selective media. J. Clin. Microbiol. [Epub ahead of print.] doi:10.1128/JCM.01470-09.
5. Castiglioni, B., D. A. Sutton, M. G. Rinaldi, J. Fung, and S. Kusne. 2002. Pseudallescheria boydii (anamorph Scedosporium apiospermum). Infection in solid organ transplant recipients in a tertiary medical center and review of the literature. Medicine (Baltimore) 81:333-348.
6. Cimon, B., J. Carrere, J. F. Vinatier, J. P. Chazalette, D. Chabasse, and J. P. Bouchara. 2000. Clinical significance of Scedosporium apiospermum in patients with cystic fibrosis. Eur. J. Clin. Microbiol. Infect. Dis. 19:53-56.
7. Cortez, K. J., E. Roilides, F. Quiroz-Telles, J. Meletiadis, C. Antachopoulos, T. Knudsen, W. Buchanan, J. Milanovich, D. A. Sutton, A. Fothergill, M. G. Rinaldi, Y. R. Shea, T. Zaoutis, S. Kottilil, and T. J. Walsh. 2008. Infections caused by Scedosporium spp. Clin. Microbiol. Rev. 21:157-197.
8. Cuenca-Estrella, M., A. Alastruey-Izquierdo, L. Alcazar-Fuoli, L. Bernal-Martinez, A. Gomez-Lopez, M. J. Buitrago, E. Mellado, and J. L. Rodriguez-Tudela. 2008. In vitro activities of 35 double combinations of antifungal agents against Scedosporium apiospermum and Scedosporium prolificans. Antimicrob. Agents Chemother. 52:1136-1139.
9. Defontaine, A., R. Zouhair, B. Cimon, J. Carrere, E. Bailly, F. Symoens, M. Diouri, J. N. Hallet, and J. P. Bouchara. 2002. Genotyping study of Scedosporium apiospermum isolates from patients with cystic fibrosis. J. Clin. Microbiol. 40:2108-2114.
10. Gavalda, J., O. Len, R. San Juan, J. M. Aguado, J. Fortun, C. Lumbreras, A. Moreno, P. Munoz, M. Blanes, A. Ramos, G. Rufi, M. Gurgui, J. Torre-Cisneros, M. Montejo, M. Cuenca-Estrella, J. L. Rodriguez-Tudela, and A. Pahissa for RESITRA (Spanish Network for Research on Infection in Transplantation). 2005. Risk factors for invasive aspergillosis in solid-organ transplant recipients: a case-control study. Clin. Infect. Dis. 41:52-59.
11. Gilgado, F., J. Cano, J. Gene, and J. Guarro. 2005. Molecular phylogeny of the Pseudallescheria boydii species complex: proposal of two new species. J. Clin. Microbiol. 43:4930-4942.
12. Gilgado, F., C. Serena, J. Cano, J. Gene, and J. Guarro. 2006. Antifungal susceptibilities of the species of the Pseudallescheria boydii complex. Anti-microb. Agents Chemother. 50:4211-4213.
13. Gilgado, F., J. Cano, J. Gene, C. Serena, and J. Guarro. 2008. Different virulence of the species of the Pseudallescheria boydii complex. Med. Mycol. 47:371-374.
14. Gilgado, F., J. Cano, J. Gene, D. A. Sutton, and J. Guarro. 2008. Molecular and phenotypic data supporting distinct species statuses for Scedosporium apiospermum and Pseudallescheria boydii and the proposed new species Scedosporium dehoogii. J. Clin. Microbiol. 46:766-771.
15. Grenouillet, F., F. Botterel, J. Crouzet, F. Larosa, Y. Hicheri, J. M. Forel, P. Helias, S. Ranque, and L. Delhaes. 2008. Scedosporium prolificans: an emerging pathogen in France? Med. Mycol. 47:343-350.
16. Guignard, S., D. Hubert, B. Dupont, P. Anract, D. Alioua, H. Guerini, A. Paugam, and M. Dougados. 2008. Multifocal Scedosporium apiospermum spondylitis in a cystic fibrosis patient. J. Cyst. Fibros. 7:89-91.
17. Howden, B. P., M. A. Slavin, A. P. Schwarer, and A. M. Mijch. 2003. Successful control of disseminated Scedosporium prolificans infection with a combination of voriconazole and terbinafine. Eur. J. Clin. Microbiol. Infect. Dis. 22:111-1113.
18. Husain, S., P. Munoz, G. Forrest, B. D. Alexander, J. Somani, K. Brennan, M. M. Wagener, and N. Singh. 2005. Infections due to Scedosporium apiospermum and Scedosporium prolificans in transplant recipients: clinical characteristics and impact of antifungal agent therapy on outcome. Clin. Infect. Dis. 40:89-99.
19. Husni, R. N., S. M. Gordon, D. L. Longworth, A. Arroliga, P. C. Stillwell, R. K. Avery, J. R. Maurer, A. Mehta, and T. Kirby. 1998. Cytomegalovirus infection is a risk factor for invasive aspergillosis in lung transplant recipients. Clin. Infect. Dis. 26:753-755.
20. Kesson, A. M., M. C. Bellemore, T. J. O'Mara, D. H. Ellis, and T. C. Sorrell. 2009. Scedosporium prolificans osteomyelitis in an immunocompetent child treated with a novel agent, hexadecylphospocholine (miltefosine), in combination with terbinafine and voriconazole: a case report. Clin. Infect. Dis. 48:1257-1261.
21. L'Hirondel, J., A. Espern, V. David, D. Horeau-Langlard, M. Besse, and F. Morio. 2008. Prévalence de la colonisation fongique au cours de la mucoviscidose: étude rétrospective sur 30 mois au CHU de Nantes, abstr. 522/ 80A, p. 235. Abstr. 28th Reun. Interdiscip. Chimiother. Anti Infect., Paris, France.
22. Li, J. Y., T. Y. Yong, D. I. Grove, and P. T. Coates. 2008. Successful control of Scedosporium prolificans septic arthritis and probable osteomyelitis without radical surgery in a long-term renal transplant recipient Transpl. Infect. Dis. 10:63-65.
23. Montoya, J. G., and F. Rosso. 2006. Is combination therapy indicated for invasive fungal infections? Yes and no. Curr. Opin. Infect. Dis. 19:357-359.
24. Morin, O., A. Haloun, M. Treilhaud, C. Sagan, and P. Boiron. 1999. Systemic mycosis due Pseudallescheria boydii in a double transplant patient with a cystic fibrosis. Study of isolated strains with RAPD (random amplification of polymorphic DNA). J. Med. Mycol. 9:119-123.
25. Rodriquez-Tudela, J. L., M. C. Arendrup, S. Arikan, F. Barchiesi, J. Bille, E. Chryssanthou, M. Cuenca-Estrella, E. Dannaoui, D. W. Denning, J. P. Donnelly, W. Fegeler, C. Lass-Flörl, C. Moore, M. Richardson, P. Gaustad, A. Schmalreck, A. Velegraki, and P. Verweij for the Subcommittee on Antifungal Susceptibility Testing (AFST) of the ESCMID European Committee for Antimicrobial Susceptibility Testing (EUCAST). 2008. EUCAST Technical Note on the method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for conidia-forming moulds. Clin. Microbiol. Infect. 14:982-984.
26. Sahi, H., R. K. Avery, O. A. Minai, G. Hall, A. C. Mehta, P. Raina, and M. Budev. 2007. Scedosporium apiospermum (Pseudallescheria boydii) infection in lung transplant recipients. J. Heart Lung Transplant. 26:350-356. (Pubitemid 46498770)
27. Solé, A., and M. Salavert. 2008. Fungal infections after lung transplantation Transplant. Rev. 22:89-104. (Pubitemid 351372918)
28. Symoens, F., C. Knoop, M. Schrooyen, O. Denis, M. Estenne, N. Nolard, and F. Jacobs. 2006. Disseminated Scedosporium apiospermum infection in a cystic fibrosis patient after double-lung transplantation. J. Heart Lung Transplant. 25:603-607.
29. Troke, P., K. Aguirrebengoa, C. Arteaga, D. Ellis, C. H. Heath, I. Lutsar, M. Rovira, Q. Nguyen, M. Slavin, and S. C. Chen. 2008. Treatment of scedosporiosis with voriconazole: clinical experience with 107 patients. Antimicrob. Agents Chemother. 52:1743-1750.
30. Widmer, F., L. C. Wright, D. Obando, R. Handke, R. Ganendren, D. H. Ellis, and T. C. Sorrell. 2006. Hexadecylphosphocholine (miltefosine) has broadspectrum fungicidal activity and is efficacious in a mouse model of cryptococcosis. Antimicrob. Agents Chemother. 50:414-421.
31. Williamson, E. C., D. Speers, I. H. Arthur, G. Harnett, G. Ryan, and T. J. Inglis. 2001. Molecular epidemiology of Scedosporium apiospermum infection determined by PCR amplification of ribosomal intergenic spacer sequences in patients with chronic lung disease. J. Clin. Microbiol. 39:47-50.